Package 75834-268-05

{"route": ["ORAL"], "spl_id": "5bad7053-8f63-45fc-adb0-88c628fa039b", "openfda": {"upc": ["0375834270609", "0375834269016"], "unii": ["207LT9J9OC"], "rxcui": ["866018", "866083", "866090", "866094", "866111"], "spl_set_id": ["b08dd2e7-e808-4b51-b404-5009076b82eb"], "manufacturer_name": ["Nivagen Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (75834-268-01)", "package_ndc": "75834-268-01", "marketing_start_date": "20210215"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (75834-268-05)", "package_ndc": "75834-268-05", "marketing_start_date": "20210215"}], "brand_name": "Buspirone Hydrochloride", "product_id": "75834-268_5bad7053-8f63-45fc-adb0-88c628fa039b", "dosage_form": "TABLET", "product_ndc": "75834-268", "generic_name": "Buspirone Hydrochloride", "labeler_name": "Nivagen Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buspirone Hydrochloride", "active_ingredients": [{"name": "BUSPIRONE HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA209696", "marketing_category": "ANDA", "marketing_start_date": "20210215", "listing_expiration_date": "20261231"}